Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $263.79 Analyst target: $309.76 Upside: 17.43%
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
See the full interactive analysis & chart →Informational only — not investment advice.